← Back to Search

Magnetic Stimulation

True Transcranial Magnetic Stimulation for Schizophrenia

Phase 4
Waitlist Available
Led By Gary Hasey, MD
Research Sponsored by St. Joseph's Healthcare Hamilton
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Schizophrenia
Auditory hallucinations occuring more than 5 times per day
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly
Awards & highlights

Study Summary

Schizophrenia is a chronic, severe, and disabling brain disease. Auditory hallucinations are the most frequent symptoms with an incident of 50% to 70% in patients. Transcranial Magnetic Stimulation (TMS) can significantly reduce symptoms of schizophrenia. TMS is capable of inducing changes in the electrical activities of the brain in humans. The purpose of this trial is to study the use of TMS to decrease auditory hallucinations in schizophrenia.

Eligible Conditions
  • Schizophrenia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hoffman Auditory Hallucination Scale
Secondary outcome measures
Positive and Negative Syndrome Scale for Schizophrenia (PANSS)

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: True Transcranial Magnetic StimulationActive Control1 Intervention
True treatment with TMS over the temporoparietal cortex.
Group II: Sham Transcranial Magnetic StimulationPlacebo Group1 Intervention
Sham treatment with rTMS over the temporoparietal cortex.

Find a Location

Who is running the clinical trial?

St. Joseph's Healthcare HamiltonLead Sponsor
196 Previous Clinical Trials
25,534 Total Patients Enrolled
2 Trials studying Schizophrenia
123 Patients Enrolled for Schizophrenia
Gary Hasey, MDPrincipal InvestigatorSt. Joseph's Health Care London
4 Previous Clinical Trials
126 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Magnetic Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia
2004. "Magnetic Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00186771.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top